Gracure Pharmaceuticals Limited — Ambroxol Exporter Profile
Indian Pharmaceutical Exporter · #7 for Ambroxol · $470.8K export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #7 Indian exporter of Ambroxol with $470.8K in export value and 19 verified shipments. Gracure Pharmaceuticals Limited holds a 3.2% market share in Ambroxol exports across 2 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Ambroxol Export Profile: Buyers & Destinations
Where Does Gracure Pharmaceuticals Limited Export Ambroxol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM, DEMOCRATIC REP. OF | $216.5K | 7 | 46.6% |
| VIETNAM | $126.6K | 4 | 27.3% |
| VIETNAM DEMOCRATIC REP. OF | $90.9K | 4 | 19.6% |
| CAMBODIA | $30.4K | 4 | 6.6% |
Gracure Pharmaceuticals Limited exports Ambroxol to 4 countries. The largest destination is VIETNAM, DEMOCRATIC REP. OF accounting for 46.6% of Gracure Pharmaceuticals Limited's Ambroxol shipments, followed by VIETNAM (27.3%) and VIETNAM DEMOCRATIC REP. OF (19.6%). These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ambroxol from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| VIETNAM CHEMICO-PHARMACEUTICAL | VIETNAM, DEMOCRATIC REP. OF | $434.0K | 15 |
| RATANAK RATANA PHARMACEUTICALS | CAMBODIA | $22.9K | 3 |
| RATANAK RATANA PHARMACEUTICALS CO. | CAMBODIA | $7.5K | 1 |
Gracure Pharmaceuticals Limited supplies Ambroxol to 3 buyers globally. The largest buyer is VIETNAM CHEMICO-PHARMACEUTICAL (VIETNAM, DEMOCRATIC REP. OF), followed by RATANAK RATANA PHARMACEUTICALS (CAMBODIA) and RATANAK RATANA PHARMACEUTICALS CO. (CAMBODIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ambroxol Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $7.8M worth of Ambroxol through 1,705 shipments from 296 suppliers to 92 countries, serving 486 buyers globally. Gracure Pharmaceuticals Limited contributes $470.8K to this total, accounting for 3.2% of India's Ambroxol exports. Gracure Pharmaceuticals Limited ships Ambroxol to 4 countries through 3 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Ambroxol Exports?
Gracure Pharmaceuticals Limited's average Ambroxol shipment value is $24.8K per consignment, based on 19 shipments totaling $470.8K. The largest destination is VIETNAM, DEMOCRATIC REP. OF (46.6% of Gracure Pharmaceuticals Limited's Ambroxol exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Ambroxol Exporters?
Gracure Pharmaceuticals Limited ranks #7 among 296 Indian Ambroxol exporters with a 3.2% market share. The top 3 exporters are WEXFORD LABORATORIES PRIVATE LIMITED ($1.4M), BIOMATRIX HEALTHCARE PRIVATE LIMITED ($1.1M), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ($958.0K). Gracure Pharmaceuticals Limited processed 19 shipments to 2 destination countries.
What Ambroxol Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OLESOM (AMBROXOL HYDROCHLORIDE SYRUP 30 | $153.7K | 5 |
| OLESOM(AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML)100ML/BTL BATCH NO.AS240018A TO AS240021ANOS | $52.1K | 3 |
| OLESOM(AMBROXOL HYDROCHLORIDE SYRUP 30 MG/5ML)100ML/BTL B.NO.AS250075A,AS250076A,MFG.DT.27/02/2025,EXP.DT.26/02/2028 | $51.3K | 2 |
| OLESOM(AMBROXOL HYDROCHLORIDE SYRUP 30MG | $50.0K | 1 |
| OLESOMAMBROXOL HYDROCHLORIDE SYRUP 30 MG/5ML 100ML/ BTL BATCH NO.AS230220A,AS230221A,AS230222A,AS230223A | $50.0K | 1 |
| OLESOM(AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML)100ML/BTL BATCH NO.AS240120AAS240122A AS240123A | $38.8K | 1 |
| OLESOM((AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML)100ML/BTL B.NO.AS250039A, AS250040A,MFG.DT.22/01/2025, EXP.DT.21/01/2028 | $25.3K | 1 |
| OLESOM-S(AMBROXOL HYDROCHLORIDE 15MG & S | $15.4K | 2 |
| OLESOM (AMBROXOL HYDROCHLORIDE SYRUP)30MG/5ML )100ML/ BTL B.NO.AS240121A, MFG.DT.11/04/2024, EXP.DT.10/04/2027 | $12.8K | 1 |
| OLESOM-S(AMBROXOL HYDROCHLORIDE 15MG SALBUTAMOL 1MG SYRUP)100ML/BTL B.NO.AS240042A MFG.DT.02/2024 EXP.DT.01/2027NOS | $7.5K | 1 |
Gracure Pharmaceuticals Limited exports 11 distinct Ambroxol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OLESOM (AMBROXOL HYDROCHLORIDE SYRUP 30 with 5 shipments worth $153.7K.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Ambroxol Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | SAVA HEALTHCARE LIMITED | $818.9K | 23 | 3 | $35.6K |
| 6 | SANPRAS HEALTHCARE PRIVATE LIMITED | $551.0K | 39 | 1 | $14.1K |
| 7 | GRACURE PHARMACEUTICALS LIMITED ★ | $470.8K | 19 | 2 | $24.8K |
| 8 | MEDICO REMEDIES LIMITED | $351.1K | 21 | 1 | $16.7K |
| 9 | ARISTO PHARMACEUTICALS PRIVATE LIMITED | $320.1K | 116 | 6 | $2.8K |
Gracure Pharmaceuticals Limited ranks #7 among 296 Indian Ambroxol exporters. Average shipment value of $24.8K compared to the market average of $26.4K. The closest competitors by value are SAVA HEALTHCARE LIMITED and SANPRAS HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Ambroxol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 289 | 17.0% |
| JNPT | 116 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 115 | 6.7% |
| MUNDRA SEA (INMUN1) | 112 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 109 | 6.4% |
| MUNDRA SEA | 86 | 5.0% |
| SAHAR AIR | 69 | 4.0% |
| AHEMDABAD ICD | 65 | 3.8% |
What Other Respiratory & OTC Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these respiratory & otc products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Ambroxol Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Ambroxol, top products include Tramadol, Albendazole, Folic, Melatonin, Celecoxib. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ambroxol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ambroxol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching Gracure Pharmaceuticals Limited exporting Ambroxol, covering 11 formulations to 4 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 486+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ambroxol Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Ambroxol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Ambroxol Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ambroxol. For current shipment-level data, contact TransData Nexus.